GSK Plans 1,217 Job Cuts Across Three Belgian Sites
The proposed cuts target office and support roles as GSK pursues a three-year global savings plan of £1.9 billion.
Key takeaways
- GSK plans to eliminate 1,217 positions at sites in Wavre, Rixensart and Gembloux.
- The cuts cover office and support roles, while production workers are excluded.
GSK plans to eliminate 1,217 positions at its sites in Wavre, Rixensart and Gembloux, according to Ekonomim. The proposed cuts affect office and support roles, while production workers are excluded.
The move is part of a three-year global transformation plan aimed at saving £1.9 billion. GSK plans to direct the resources toward advanced-stage drug projects and research.
Ekonomim reports that GSK employs around 8 thousand people in Belgium and is expected to remain the country’s largest biopharma employer despite the planned cuts.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.
